Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1986 Apr;29(4):639-44.
doi: 10.1128/aac.29.4.639.

Genetic and Biochemical Characterization of Norfloxacin Resistance in Escherichia Coli

Free PMC article

Genetic and Biochemical Characterization of Norfloxacin Resistance in Escherichia Coli

D C Hooper et al. Antimicrob Agents Chemother. .
Free PMC article

Abstract

In Escherichia coli the frequency of spontaneous single-step mutation to high levels of resistance to the newer 4-quinolone agent norfloxacin was confirmed to be over 300-fold lower than that to the older agent nalidixic acid. Serial passage on incremental concentrations of drug was necessary to produce mutants highly resistant to norfloxacin. Genetic analysis of one such highly resistant strain identified two mutations conferring drug resistance. One mutation, nfxA, mapped around 48 min on the E. coli genetic map and was shown to be an allele of gyrA by studies demonstrating an increased drug resistance of DNA gyrase reconstituted with the gyrase A subunit isolated from the mutant strain. These findings also identified the DNA gyrase A subunit as a target of norfloxacin. The second mutation, nfxB, mapped between 20 and 22 min was associated with additional resistances to tetracycline, chloramphenicol, and cefoxitin and with decreases in outer membrane porin protein OmpF. The nfxA and nfxB mutations together accounted for most, but not all, of the norfloxacin resistance phenotype of this strain.

Similar articles

See all similar articles

Cited by 92 articles

See all "Cited by" articles

References

    1. N Engl J Med. 1966 Nov 17;275(20):1081-9 - PubMed
    1. J Bacteriol. 1984 Jan;157(1):262-8 - PubMed
    1. J Bacteriol. 1969 Jul;99(1):238-41 - PubMed
    1. Biochemistry. 1971 Jun 22;10(13):2606-17 - PubMed
    1. J Bacteriol. 1971 Dec;108(3):1224-34 - PubMed

Publication types

Substances

Feedback